WHO Adds GLP-1 Drugs for Diabetes, Others to Essential Medicines List
The World Health Organization has added GLP-1 drugs to treat diabetes to its essential medicines list alongside treatments for cystic fibrosis and cancer, and said it hopes… Reuters Health Information
Trend tracker: Spotlight on China’s infant formula market, biotics, eye health
Find out more about recent trends in China’s infant formula sales, eye health supplement ingredients, and biotics for GLP-1 in this round-up.
The GLP-1 Effect: A New Path to Male Fertility?
Explore how GLP-1 therapies, beyond weight loss and diabetes care, may influence male fertility by improving hormonal balance, metabolism, and reproductive health outcomes.
GLP-1 Agonists Show Possible Benefits for Rare Blood Cancer
(MedPage Today) — HOUSTON — Patients with polycythemia vera (PV) and a history of treatment with GLP-1 agonists had significantly lower rates of multiple adverse outcomes associated with the disease, a large propensity-matched study showed…
CVS Facing Lawsuit for Supporting Wegovy Over Other GLP-1s
CVS Health Corp.’s pharmacy benefit manager Caremark RX LLC is facing a lawsuit challenging its decision to stop coverage of weight loss drug Zepbound in favor of Wegovy, another GLP-1 drug. In …
SupplySide Global 2025 to Spotlight Transformative Industry Trends in Artificial Intelligence, Natural Colors, GLP-1 Innovations and Global Trade Impacts – The Globe and Mail
SupplySide Global 2025 to Spotlight Transformative Industry Trends in Artificial Intelligence, Natural Colors, GLP-1 Innovations and Global Trade Impacts The Globe and Mail
Why GLP‑1 drugs should be covered beyond weight loss
When I turned 50, I weighed 265 pounds. Over the next 12 years, through walking, yoga, and strength training, I lost 60 pounds and kept it off. But despite the discipline, I remained plagued by inflammation, pain, and sleep apnea. Then last year, my doctor suggested tirzepatide (Zepbound), not just for weight loss but to […]
GLP-1 Use After Bariatric Surgery on the Rise
An increasing proportion of bariatric surgery patients are taking GLP-1 weight-loss drugs in the years following their surgery. Medscape Medical News
Weight-loss drug semaglutide shown to reduce cocaine use in rats
Scientists have found that the diabetes/weight loss drug semaglutide, sold commercially under brand names like Ozempic and Wegovy, significantly reduces cocaine-seeking behavior in rats. This work needs to be confirmed in humans, but it suggests that semaglutide is a candidate to be developed as a treatment for cocaine dependency; at the moment there is no effective pharmacological treatment for cocaine dependency.
MeAgain – Navigate your GLP-1 Journey
MeAgain is designed specifically for people on GLP-1 medications like Ozempic®, Wegovy®, Mounjaro®, Zepbound®, generics and compounds. MeAgain helps you build and stay on track with your new habits, manage side effects, and ensure you feel like you again soon. View startup